National Health Investors, Inc.
NHI · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $335,181 | $319,835 | $278,194 | $298,715 |
| % Growth | 4.8% | 15% | -6.9% | – |
| Cost of Goods Sold | $11,165 | $11,513 | $9,788 | $11,638 |
| Gross Profit | $324,016 | $308,322 | $268,406 | $287,077 |
| % Margin | 96.7% | 96.4% | 96.5% | 96.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $21,788 | $19,821 | $25,323 | $19,339 |
| SG&A Expenses | $21,788 | $19,821 | $25,323 | $19,339 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $118,372 | $109,709 | $110,317 | $82,486 |
| Operating Expenses | $140,160 | $129,530 | $135,640 | $101,825 |
| Operating Income | $183,856 | $178,792 | $132,766 | $185,252 |
| % Margin | 54.9% | 55.9% | 47.7% | 62% |
| Other Income/Exp. Net | -$47,262 | -$44,411 | -$67,354 | -$73,219 |
| Pre-Tax Income | $136,594 | $134,381 | $65,412 | $112,033 |
| Tax Expense | -$45 | $0 | -$89 | $66 |
| Net Income | $137,985 | $135,654 | $66,403 | $111,804 |
| % Margin | 41.2% | 42.4% | 23.9% | 37.4% |
| EPS | 3.14 | 3.13 | 0.52 | 1.36 |
| % Growth | 0.3% | 501.9% | -61.8% | – |
| EPS Diluted | 3.13 | 3.13 | 0.51 | 1.36 |
| Weighted Avg Shares Out | 43,845 | 43,389 | 44,775 | 45,714 |
| Weighted Avg Shares Out Dil | 44,103 | 43,389 | 44,794 | 45,729 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$2,647 | $0 | $0 |
| Interest Expense | $56,120 | $55,513 | $42,441 | $48,112 |
| Depreciation & Amortization | $71,443 | $69,973 | $70,880 | $80,798 |
| EBITDA | $264,157 | $259,867 | $178,733 | $240,943 |
| % Margin | 78.8% | 81.3% | 64.2% | 80.7% |